S1207 (breast cancer trial)

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:clinical_trial
gptkbp:allocates	randomized
gptkbp:clinicalTrials.gov_Identifier	NCT01674140
gptkbp:collaboratesWith	gptkb:National_Cancer_Institute
gptkbp:condition	gptkb:cancer
gptkbp:eligibility	female male 18 years and older
gptkbp:endpoint_classification	efficacy study
gptkbp:enrollment	3460
gptkbp:fullName	S1207: Endocrine Therapy With or Without Everolimus in Treating Patients With Breast Cancer
https://www.w3.org/2000/01/rdf-schema#label	S1207 (breast cancer trial)
gptkbp:intervention	gptkb:everolimus endocrine therapy
gptkbp:location	gptkb:Canada gptkb:Puerto_Rico gptkb:United_States
gptkbp:mask	none (open label)
gptkbp:period	Phase III
gptkbp:primary_completion_date	December 2023
gptkbp:purpose	gptkb:psychotherapy
gptkbp:randomized	yes
gptkbp:sponsor	gptkb:SWOG_Cancer_Research_Network
gptkbp:startDate	September 2012
gptkbp:status	Active, not recruiting
gptkbp:study_type	interventional
gptkbp:bfsParent	gptkb:SWOG_Cancer_Research_Network
gptkbp:bfsLayer	7